PBM Audit Defense Strategies for Independent Pharmacies

PBM audit defense strategies matter more this year than in most previous ones. Audits themselves are increasing fast and PBMs have gotten considerably more precise about what they target. This is not a rare event you can afford to plan for reactively. It is a recurring operational risk that deserves a standing defense, not a scramble after the fact.

WSPC built this guide around what PAAS National, an organization that has spent decades helping pharmacies navigate exactly this process, has shared publicly about current audit trends and effective defense. This guide covers what is actually being targeted, what a pharmacy can do proactively, and how to respond once a notice actually arrives, drawing on real data reported by Drug Topics and Pharmacy Times.

How Much Have PBM Audits Actually Increased?

PBM audits have increased significantly in recent years, with data showing a meaningful year-over-year rise specifically affecting independent pharmacies, not a general, evenly distributed trend across the industry.

Drug Topics reported a 17% year-over-year increase in audits targeting independent pharmacies, citing PAAS National data presented at the NCPA 2024 Annual Convention. Separately, PBM audits rose as much as 29% in 2023. Many pharmacists who failed audits cited them as the primary reason they could not stay in business. These are not abstract statistics. They represent a direct, rising threat to independent pharmacy survival, and the trend shows no clear sign of reversing on its own without deliberate preparation on the pharmacy's side.

This trend line matters for planning purposes. Audit preparation used to be something an owner could reasonably deprioritize. The current data suggests it now deserves the same standing attention as inventory management or staff scheduling, not an occasional afterthought handled only when a notice arrives. With a 17% year-over-year rise in audits and up to a 29% spike in a single prior year, the frequency alone justifies building a standing defense process rather than treating each audit as an isolated surprise.

What Specifically Do PBMs Target During an Audit?

PBMs specifically target high-dollar claims and insulin products, along with proof of dispensing and proof of copay collection, which have become heavily scrutinized areas over the last two years according to PAAS National.

Trent Thiede, PharmD, MBA, president of PAAS National, explained in a Drug Topics interview that PBMs know exactly what they are looking for. Audits are targeted, not random. Basic elements like state and federal prescription requirements get checked routinely. Proof of dispensing and proof of copay collection specifically have ramped up as focus areas in recent years. This reflects where PBMs believe they can find the most recoverable discrepancies, as Pharmacy Times has separately reported.

Audit Focus Area	Why It Matters
High-dollar claims, insulin	Largest potential recovery per claim
Proof of dispensing and copay collection	Newer, rapidly growing focus areas

Knowing these priorities gives you somewhere concrete to start if you cannot audit-proof everything at once. Reviewing your documentation practices specifically for insulin claims and copay collection first addresses the areas most likely to draw attention right now, rather than spreading limited time evenly across every claim type.

What Can a PBM Actually Recover in an Audit?

A PBM can recover the entire reimbursement amount paid on a claim if documentation does not adequately support it, and may add an audit fee proportionate to the recovery on top of the clawback itself.

Drug Topics has reported that audits can also lead to additional sanctions beyond the financial clawback, including payment suspension or, in severe cases, network termination. This is precisely why documentation discipline matters so much.

The All-or-Nothing Clawback

A single missing signature or an incomplete proof-of-copay record can mean losing the entire reimbursement on that claim, not just a partial adjustment. Multiply that risk across dozens of claims in a single audit, and the stakes become clear enough to justify real investment in getting documentation right the first time.

1. Keep complete documentation for every dispensed claim, not just high-dollar ones.
2. Retain copay collection records systematically, since this is now a heavily audited area.
3. Store documentation in a way that is quickly retrievable when an audit request arrives.

The all-or-nothing nature of these clawbacks is what makes documentation discipline so consequential. A pharmacy is not risking a small percentage adjustment on a disputed claim. It is risking the entire reimbursement plus a fee, which changes the math significantly on how much time is worth investing in getting documentation right up front.

What Are the Best PBM Audit Defense Strategies for Prevention?

Proactive habits that reduce audit risk include regular internal documentation reviews and staff training refreshed periodically rather than once at hiring. Treat every insulin or high-dollar claim with the same documentation rigor you would want if it were audited tomorrow morning.

• Schedule a recurring monthly documentation spot-check, not an occasional one
• Refresh staff training periodically, not just once at hiring
• Prioritize insulin and high-dollar claims first if time is limited

Waiting for an audit to reveal a documentation gap is the most expensive way to discover it. A short monthly internal review, even spot-checking a handful of high-dollar claims for complete documentation, catches small gaps before they compound across hundreds of claims.

This costs a fraction of the time an actual audit response demands, and it builds the habit of treating documentation as routine rather than reactive. Assign this review to a specific staff member on a specific recurring day, rather than leaving it as a vague, unowned task that quietly never happens. Rotating who performs the review periodically also helps catch blind spots that the same reviewer might otherwise miss month after month.

Should Audit Prevention Be One Pharmacist's Job?

No, audit prevention should not fall on one pharmacist alone. PAAS National leadership specifically recommends a team-based approach, since training and vigilance spread across the full staff catches far more potential issues than any single person working in isolation ever could.

Train the Whole Team, Not Just the Pharmacist

Thiede made this point directly, noting that a team approach, not just the dispensing pharmacist, is essential, since no single person catches every possible issue alone. Practically, this means training technicians and front-end staff on what documentation matters, not just pharmacists. A missing copay record noticed by a technician at the counter is far cheaper to fix in the moment than discovering it months later during an audit.

Building this awareness into new-hire training, not just an occasional reminder, keeps the standard consistent even as staff turns over across the years. A brief documentation checklist posted at the register or built into your dispensing workflow reinforces the habit without requiring anyone to memorize every rule.

What Should a Pharmacy Do the Moment an Audit Notice Arrives?

A pharmacy should immediately review the audit request in full, confirm the deadline, and begin gathering the specific documentation requested, rather than delaying the response or assuming the request is routine and low-priority.

The First 48 Hours

Most audits start with a document request tied to specific claims. Respond completely and on time. Missing the response deadline can itself trigger a worse outcome than the original discrepancy would have. If the PBM issues initial audit results identifying discrepancies, review each one carefully alongside the appeal deadline and method, since these findings are a starting point for negotiation, not a final verdict. Assign one person ownership of the response from the moment the notice arrives, so nothing falls through the cracks during a busy week at the pharmacy, and set an internal reminder well ahead of the actual deadline.

How Serious Is the Network Termination Risk?

Network termination risk is genuinely serious, since a pattern of failed audits or unresolved discrepancies can lead a PBM to remove a pharmacy from its network entirely, cutting off access to every patient covered under that plan.

This is the outcome that separates a routine audit inconvenience from an existential threat to the business. A single audit rarely triggers termination on its own, but a documented pattern of repeated issues raises that risk substantially. Treat repeated audit findings, even ones you have successfully appealed, as a signal to review your documentation process more broadly rather than simply closing each individual case and moving on. Losing network access on a major plan can affect a meaningful share of your patient base overnight. That risk is precisely why prevention deserves more attention than most owners initially give it. If your pharmacy has faced repeated audits from the same PBM, that pattern itself is worth a candid internal review, not just a series of individually handled disputes treated as unrelated events.

Is It Worth Appealing PBM Audit Findings?

Yes, appealing PBM audit findings is generally worth the effort, since initial audit results frequently include discrepancies that can be resolved with additional documentation or clarification the pharmacy did not initially submit to the auditor.

Pharmacies that treat initial findings as final, without pursuing the appeal process, often leave money on the table that a more thorough documentation submission could have recovered. Understand the specific basis for each discrepancy, gather any supporting records you may not have initially provided, and submit a complete appeal before the deadline rather than a partial or rushed one. Keep a copy of everything submitted, including the original request and your full response, in case the dispute continues beyond the first appeal. A well-organized appeal file also makes any future audit from the same PBM considerably easier to handle.

PBM audit defense strategies work best as an everyday habit, not a reaction to a notice that just arrived. Train your whole team on documentation, focus extra attention on high-dollar claims and copay collection, and treat any audit finding as a starting point for appeal rather than a final answer. Audits are not going away. A pharmacy that prepares consistently faces them from a position of strength rather than panic, with far less financial exposure when a notice does eventually arrive at your door.

This article is general educational information for independent pharmacy owners and operators and is not legal, financial, tax, or regulatory advice. Verify current requirements and consult qualified professionals before acting. WSPC provides resources and advocacy for independent community pharmacies.